Success Story: Strengthening T-Cell Immunotherapy Research Leads to I-140 NIW Approval
Client’s Testimonial:
"Thank you so much for the wonderful news! I am absolutely thrilled to hear that my I-140 NIW petition has been approved. Thank you very much for your hard work and guidance throughout this process.”
On June 13th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Student in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Graduate Student
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: June 13th, 2026
Processing Time: 21 months, 23 days (Premium Processing Upgrade Requested)
Case Summary:
We are pleased to share that the client’s I-140 National Interest Waiver petition was approved. With a master’s degree in microbiology and immunology, the client has built a focused record in immunology research, particularly in improving T-cell-based immunotherapies for cancer and chronic infections such as HIV and HBV. The client’s proposed endeavor centered on developing innovative strategies to prevent the exhaustion differentiation of cytotoxic CD8 T cells. This research is important because T-cell exhaustion remains a major barrier to effective and durable immunotherapy. By identifying transcription factors that regulate T-cell differentiation, the client’s work supports the broader goal of enhancing treatment outcomes for serious diseases that continue to affect public health in the United States.
To demonstrate the client’s significance, we organized the petition around objective evidence showing both scientific productivity and independent reliance by the field. The client’s record included:
- 5 peer-reviewed journal articles, including 2 first-authored papers, and 1 abstract
- 140 citations to the client’s publications
- At least 3 completed peer reviews
- Research support connected to major funding sources
Rather than presenting these metrics as sufficient on their own, the petition explained how an adjudicator could interpret them as evidence of meaningful field recognition. The citation record showed that other researchers had relied on the client’s findings in immunology, while the peer-review invitations reflected trust in the client’s expertise. The funding evidence further supported the national relevance of the research, particularly its connection to cancer, HIV, and chronic infection treatment priorities.
The petition also highlighted the client’s current research role in immunology and future plan to continue work in the field. By linking the client’s education, publication record, citation influence, peer-review service, and funded research environment to the proposed endeavor, we demonstrated that the client was well-positioned to advance work with substantial merit and national importance.
We congratulate the client on this I-140 NIW approval and wish the client continued success in advancing immunology research that may contribute to stronger and more durable therapeutic strategies.